3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is ever more attracting clinical attention due to initial evidence suggesting unique pharmacological characteristics. Present analyses suggest https://www.pinterest.com/pin/1140888518124046392/